drugset / Trial / NCT07632157

MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation

NCT07632157

Phase 3 Not yet recruiting 196 enrolled Wake Forest University Health Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this research study is to find out if the use of magnesium in addition to Metoprolol, a rate controlling medication that you would be offered in the Emergency Department today unrelated to this study, will help reduce your high heart rate (rapid ventricular response).

Timeline

Start
2026-10
Primary completion
2028-12
Completion
2028-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 2 g Intravenous
Subject Magnesium Sulfate Other / unclassified 4 g Intravenous

Indications